Glenmark, Strides Pharma, Cipla recall products in the US due to manufacturing issues

The Drug Suppliers for Glenmark, Strides Pharma and Cipla are recalling products in the Globally vast market (U.S) as there was production issues. As the per the Survey done by US Food and Drug Administration, they submitted a report stating that Glenmark Pharmaceuticals Inc based on New Jersey i...

CIPLA THERAPEUTICS TO PARTNER WITH US-BASED SIGA TECHNOLOGIES TO DEVELOP NOVEL ANTIBIOTICS

Highlights

• Cipla Ltd said its US speciality business division has entered into agreement with US-based SIGA Technologies Inc to develop novel antibiotics

• Cipla Therapeutics has decided to partner with SIGA Technologies in order to develop novel antibiotics, speci...

5 STATES INCLUDING MAHARASHTRA, DELHI RECEIVE FIRST BATCH OF COVIFOR

Highlights

• 100-milligram vial of COVIFOR will cost Rs 5,400 and presently is available through hospitals and government only

• Hetero plans to produce one lakh vials of COVIFOR in coming two to three weeks

• Cipla signed licensing agreement with Gile...